#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Retinal Nerve Fiber Layer and Ganglion Cell Complex Thickness Analysis in Treatment –⁠ Naive Glaucoma Patients


Authors: Kumar Sushil 1;  Kumar Ashok 1;  Singh Ankita 2;  Bhatkoti Bhupesh 1;  Sharma Kumar Vijay 1;  Ambiya Vikas 1;  Rana Vipin 3
Authors‘ workplace: Department of Ophthalmology, Armed Forces Medical College, Pune-40, India 1;  Department of Ophthalmology, Military Hospital, Bhatinda, Punjab, India 2;  Department of Ophthalmology, Command Hospital, Kolkata, West Bengal, India 3
Published in: Čes. a slov. Oftal., 82, 2026, No. 5, p. 247-254
Category: Original Article
doi: https://doi.org/10.31348/2026/5

Overview

Aim: To evaluate RNFL (Retinal Nerve Fiber Layer) and GCC (Ganglion Cell Complex) thickness, using SD-OCT in treatment-naive patients of primary open-angle glaucoma (POAG), primary angle-closure glaucoma (PACG) and normal-tension glaucoma (NTG) and to compare these findings with healthy controls.

Material and Methods: The study included 150 eyes of 75 glaucoma patients (25 each of POAG, PACG, NTG) and 200 eyes of 100 controls. In this cross-sectional observational study, patients meeting the inclusion criteria underwent comprehensive ophthalmic examinations, including best-corrected visual acuity, intraocular pressure (IOP) by Goldmann applanation tonometry (GAT), gonioscopy to differentiate between open and closed angle and visual field analysis (VFA). GCC-IPL and RNFL thickness were measured using SD-OCT.

Results: Significant thinning of RNFL was noted in all glaucoma subtypes, especially in inferior and superior quadrants (p < 0.0001). GCC also showed thinning, notably in inferior and superior sectors, although the average GCC reduction was not statistically significant overall (p = 0.0611). Visual field mean deviation (MD) was worse in glaucoma eyes (-2.69 dB) compared to controls (-0.89 dB, p = 0.041), reflecting functional loss. POAG and NTG showed more prominent GCC, RNFL, VF correlations than PACG.

Conclusion: The study highlights that RNFL remains a robust early biomarker of glaucomatous damage, while inferior and superior GCC thickness may enhance sensitivity in detecting early structural changes, especially in treatment-naive patients. Combining RNFL and GCC analysis with VFA strengthens early diagnosis and subtype differentiation in treatment-naive primary glaucoma.

Keywords:

optical coherence tomography – glaucoma – retinal nerve fiber layer – ganglion cell complex – visual field analysis


Sources

1. Kastner A, King AJ. Advanced glaucoma at diagnosis: current perspectives. Eye. 2020 Jan;34(1):116-128.

2. Borrás T. Gene expression in the trabecular meshwork and the influence of intraocular pressure. Progress in retinal and eye research. 2003 Jul 1;22(4):435-463.

3. Nunes HF, Ananina G, Costa VP, Zanchin NI, de Vasconcellos JP, de Melo MB. Investigation of CAV1/CAV2 rs4236601 and CDKN2B-AS1 rs2157719 in primary open-angle glaucoma patients from Brazil. Ophthalmic genetics. 2018 Mar 4;39(2):194-199.

4. Devalla SK, Liang Z, Pham TH, et al. Glaucoma management in the era of artificial intelligence. British Journal of Ophthalmology. 2020 Mar 1;104(3):301-311.

5. Kansal V, Armstrong JJ, Pintwala R, Hutnik C. Optical coherence tomography for glaucoma diagnosis: an evidence based meta-analysis. PloS one. 2018 Jan 4;13(1):e0190621.

6. Tan O, Chopra V, Lu AT, et al. Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography. Ophthalmology. 2009 Dec 1;116(12):2305-2314.

7. Feng L, Zhao Y, Yoshida M, et al. Sustained Ocular Hypertension Induces Dendritic Degeneration of Mouse Retinal Ganglion Cells That Depends on Cell Type and Location. Investig. Ophthalmol. Vis. Sci. 2013;54 : 1106-1117.

8. Dascalescu D, Corbu C, Coviltir V, et al. The ganglion cell complex is an useful tool in glaucoma assessment. Romanian Journal of Ophthalmology. 2018 Oct;62(4):300.

9. Feng L, Zhao Y, Yoshida M, et al. Sustained ocular hypertension induces dendritic degeneration of mouse retinal ganglion cells that depend on cell type and location. Investigative ophthalmology & visual science. 2013 Feb 1;54(2):1106-1117.

10. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126(4):487-497.

11. Medeiros FA. Biomarkers and surrogate endpoints in glaucoma clinical trials. Br J Ophthalmol. 2015;99(5):599-603. doi:10.1136/ bjophthalmol-2014-305550

12. Bussel II, Wollstein G, Schuman JS. OCT for glaucoma diagnosis, screening and detection of glaucoma progression. Br J Ophthalmol. 2014;98 Suppl 2(Suppl 2):15-19.

13. Oddone F, Lucenteforte E, Michelessi M, et al. Macular versus Retinal Nerve Fiber Layer Parameters for Diagnosing Manifest Glaucoma: A Systematic Review of Diagnostic Accuracy Studies. Ophthalmology. 2016;123(5):939-949.

14. Sung KR, Wollstein G, Kim NR, et al. Macular assessment using optical coherence tomography for glaucoma diagnosis. Br J Ophthalmol. 2012;96(12):1452-1455.

15. Begum VU, Addepalli UK, Yadav RK, et al. Ganglion cell-inner plexiform layer thickness of high definition optical coherence tomography in perimetric and preperimetric glaucoma. Invest Ophthalmol Vis Sci. 2014;55(8):4768-4775.

16. Mwanza JC, Durbin MK, Budenz DL, et al. Glaucoma diagnostic accuracy of ganglion cell-inner plexiform layer thickness: comparison with nerve fiber layer and optic nerve head. Ophthalmology. 2012;119(6):1151-1158.

17. Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol. 1982;100(1):135-146.

18. Harwerth RS, Wheat JL, Fredette MJ, Anderson DR. Linking structure and function in glaucoma. Prog Retin Eye Res. 2010;29(4):249-271.

19. Quigley HA, Miller NR, George T. Clinical evaluation of nerve fiber layer atrophy as an indicator of glaucomatous optic nerve damage. Arch Ophthalmol. 1980;98(9):1564-1571.

20. Sommer A, Katz J, Quigley HA, et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol. 1991;109(1):77-83.

21. Schuman JS, Hee MR, Puliafito CA, et al. Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol. 1995;113(5):586-596.

22. Leung CK, Cheung CY, Weinreb RN, et al. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a variability and diagnostic performance study. Ophthalmology. 2009;116(7):1257-1263.e1-2.

23. Leite MT, Rao HL, Weinreb RN, et al. Agreement among spectral-domain optical coherence tomography instruments for assessing retinal nerve fiber layer thickness. Am J Ophthalmol. 2011;151(1):85-92.

24. Curcio CA, Allen KA. Topography of ganglion cells in human retina. J Comp Neurol. 1990;300(1):5-25.

25. Leung CK, Yu M, Weinreb RN, et al. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a prospective analysis of age-related loss. Ophthalmology. 2012;119(4):731 -⁠ 737.

26. Mondal LK, Baidya KP, Bhattacharya B, Giri P, Goswami S. Optical coherence tomography in glaucoma-I: Principle, technique and interpretation. J Clin Ophthalmol Res 2018; 6 : 153-157.

27. Leung CK, Choi N, Weinreb RN, et al. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: pattern of RNFL defects in glaucoma. Ophthalmology. 2010;117(12):2337 -⁠ 2344.

28. Um TW, Sung KR, Wollstein G, Yun SC, Na JH, Schuman JS. Asymmetry in hemifield macular thickness as an early indicator of glaucomatous change. Invest Ophthalmol Vis Sci. 2012;53(3):1139-1144.

29. Asrani S, Rosdahl JA, Allingham RR. Novel software strategy for glaucoma diagnosis: asymmetry analysis of retinal thickness. Arch Ophthalmol. 2011;129(9):1205-1211.

30. Nakano N, Hangai M, Nakanishi H, et al. Macular ganglion cell layer imaging in preperimetric glaucoma with speckle noise-reduced spectral domain optical coherence tomography. Ophthalmology. 2011;118(12):2414-2426.

31. Tan O, Chopra V, Lu AT, et al. Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography. Ophthalmology. 2009;116(12):2305-2314.e1-2.

32. Budenz DL, Michael A, Chang RT, McSoley J, Katz J. Sensitivity and specificity of the Stratus OCT for perimetric glaucoma. Ophthalmology. 2005;112(1):3-9.

33. Schulze A, Lamparter J, Pfeiffer N, Berisha F, Schmidtmann I, Hoffmann EM. Diagnostic ability of retinal ganglion cell complex, retinal nerve fiber layer, and optic nerve head measurements by Fourier-domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2011;249(7):1039-1045.

34. Kotowski J, Folio LS, Wollstein G, et al. Glaucoma discrimination of segmented cirrus spectral domain optical coherence tomography (SD-OCT) macular scans. Br J Ophthalmol. 2012;96(11):1420-1425.

35. Nakatani Y, Higashide T, Ohkubo S, Takeda H, Sugiyama K. Evaluation of macular thickness and peripapillary retinal nerve fiber layer thickness for detection of early glaucoma using spectral domain optical coherence tomography. J Glaucoma. 2011;20(4):252-259.

36. Garway-Heath DF, Holder GE, Fitzke FW, Hitchings RA. Relationship between electrophysiological, psychophysical, and anatomical measurements in glaucoma. Invest Ophthalmol Vis Sci. 2002;43(7):2213-2220.

Labels
Ophthalmology
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#